Dianne Spillman, BS

Dianne Spillman is the Team Leader and Project Management Officer for the Oncology Program at the FDA. The Oncology Program works with Centers within FDA and with external stakeholders to initiate, develop, co-ordinate, and communicate cross-cutting FDA initiatives in oncology. The Program’s strategic goals are to identify emerging technologies that may speed the development of new therapies for cancer, examine the regulatory implications of such breakthroughs, and devise strategies for consistent, rational alignment of regulatory policy with scientific advances. Major areas of focus in the program include the FDA’s Critical Path Initiative, Pharmacogenomics, and the Clinical Data Interchange Standards Consortium (CDISC), and conducting clinical trials.